Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)
CMH-2013-02
Phase 3 small_molecule active
Quick answer
Trimebutine Maleate (NEWBUTIN SR 300 mg Tab) for Nausea is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Nausea
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active